Cirrhosis: References

1. Lochs H, Plauth M. Liver cirrhosis: rationale and modalities for nutritional support—the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care. 1999;2:345–349.

2. Gheorghe L, Iacob R, Vadan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high–calorie high–protein diet. Rom J Gastroenterol. 2005;14:231–238.

3. Amodio P, Caregaro L, Patteno E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis. 2001;33:492–500.

4. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology. 1998;27:264–272.

5. Gauthier A, Levy VG, Quinton A, et al. Salt or no salt in the treatment of cirrhotic ascites: a randomised study. Gut. 1986;27:705–709.

6. Nanji AA, French SW. Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res. 1986;10:271–273.

7. Rotily M, Durbec JP, Berthezene P, Sarles H. Diet and alcohol in liver cirrhosis: a case–control study. Eur J Clin Nutr. 1990;44:595–603.

8. Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol. 1995;142:1136–1146.

9. Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis. 2005;9:67–81.

10. Chari S, Gupta M. Status of blood antioxidant enzymes in alcoholic cirrhosis.
Indian J Physiol Pharmacol. 2003;47:343–346.

11. Van de Casteele M, Zaman Z, Zeegers M, Servaes R, Fevery J, Nevens F. Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself. Aliment Pharmacol Ther. 2002;16:985–992.

12. Yadav D, Hertan HI, Schweitzer P, Norkus EP, Pitchumoni CS. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97:2634–2639.

13. Halifeoglu I, Gur B, Aydin S, Ozturk A. Plasma trace elements, vitamin B12, folate, and homocysteine levels in cirrhotic patients compared with healthy controls. Biochemistry (Mosc). 2004;69:693–696.

14. Bosy–Westphal A, Ruschmeyer M, Czech N, et al. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr. 2003;77:1269–1277.

15. Adinolfi LE, Ingrosso D, Cesaro G, et al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology. 2005;41:995–1003.

16. Ventura P, Rosa MC, Abbati G, et al. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. Liver Int. 2005;25:49–56.

17. Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched–chain amino acids as a protein– and energy–source in liver cirrhosis. Biochem Biophys Res Commun. 2004;313:405–409.

18. Laviano A, Muscaritoli M, Cascino A, et al. Branched–chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care. 2005;8:408–414.

19. Muto Y, Sato S, Watanabe A, et al. Effects of oral branched–chain amino acid granules on event–free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3:705–713.

20. Cabre E, Gassull MA. Nutritional aspects of liver disease and transplantation. Curr Opin Clin Nutr Metab Care. 2001;4:581–589.

21. Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.

22. Zhao HY, Wang HJ, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis. 2004;5:64–67.

23. Loguercio C, Federico A, Tuccillo C, et al. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol. 2005;39:540–543.